Similarly, antibody-mediated neutralization of HMGB1 has been shown to attenuate glial cell activation and prevent neuron loss in models of both Alzheimer’s disease and Parkinson’s disease (21, 48). Here, HMGB1 is linked to Alzheimer disease.